220 related articles for article (PubMed ID: 3145467)
21. Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts.
He XM; Wikstrand CJ; Friedman HS; Bigner SH; Pleasure S; Trojanowski JQ; Bigner DD
Lab Invest; 1991 Jun; 64(6):833-43. PubMed ID: 1904513
[TBL] [Abstract][Full Text] [Related]
22. Medulloblastoma: histological evaluation and prognosis. A clinical, immunohistochemical and electron microscopic study.
Szymas J; Biczysko W; Gabryel P; Morkowski S
Childs Nerv Syst; 1987; 3(2):74-80. PubMed ID: 3304626
[TBL] [Abstract][Full Text] [Related]
23. Glial fibrillary acidic protein in medulloblastoma.
Mannoji H; Takeshita I; Fukui M; Ohta M; Kitamura K
Acta Neuropathol; 1981; 55(1):63-9. PubMed ID: 7348008
[TBL] [Abstract][Full Text] [Related]
24. [Immunohistochemical studies of hemangioblastoma with glial fibrillary acidic protein].
Mannoji H; Takeshita I; Fukui M; Kitamura K
No To Shinkei; 1983 Dec; 35(12):1207-16. PubMed ID: 6367779
[TBL] [Abstract][Full Text] [Related]
25. Morphological, immunocytochemical and flow cytometric in vitro characterisation of a surface-adherent medulloblastoma.
Parker K; Pilkington GJ
Anticancer Res; 2005; 25(6B):3855-63. PubMed ID: 16309171
[TBL] [Abstract][Full Text] [Related]
26. Medulloblastoma with lipidized cells versus lipomatous medulloblastoma.
Giordana MT; Schiffer P; Boghi A; Buoncristiani P; Benech F
Clin Neuropathol; 2000; 19(6):273-7. PubMed ID: 11128619
[TBL] [Abstract][Full Text] [Related]
27. Glial fibrillary acidic protein in medulloblastomas.
Kumanishi T; Washiyama K; Watabe K; Sekiguchi K
Acta Neuropathol; 1985; 67(1-2):1-5. PubMed ID: 4024863
[TBL] [Abstract][Full Text] [Related]
28. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
29. Relationship of the demonstration of intermediate filament protein to kinetics of three human neuroepithelial tumor cell lines. Lack of neural-related proteins in most cells in S phase: a double-labeled immunohistochemical study on matrix cultures.
Ibayashi N; Herman MM; Boyd JC; Bigner DD; Friedman HS; Collins VP; Donoso LA; Rubinstein LJ
Lab Invest; 1989 Sep; 61(3):310-8. PubMed ID: 2504992
[TBL] [Abstract][Full Text] [Related]
30. An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors.
Kimura T; Budka H; Soler-Federsppiel S
Clin Neuropathol; 1986; 5(1):21-7. PubMed ID: 3512139
[TBL] [Abstract][Full Text] [Related]
31. Co-expression of four intermediate filament subclasses in childhood glial neoplasms.
Bodey B; Cosgrove M; Gonzalez-Gomez I; Siegel SE; Martin SE; Gilles FH
Mod Pathol; 1991 Nov; 4(6):742-9. PubMed ID: 1724088
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
[TBL] [Abstract][Full Text] [Related]
33. Neuron-specific enolase and neurofilament protein as markers of differentiation in medulloblastoma.
Velasco ME; Ghobrial MW; Ross ER
Surg Neurol; 1985 Feb; 23(2):177-82. PubMed ID: 3917581
[TBL] [Abstract][Full Text] [Related]
34. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system.
Pietsch T; Scharmann T; Fonatsch C; Schmidt D; Ockler R; Freihoff D; Albrecht S; Wiestler OD; Zeltzer P; Riehm H
Cancer Res; 1994 Jun; 54(12):3278-87. PubMed ID: 8205550
[TBL] [Abstract][Full Text] [Related]
35. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
Grotzer MA; Hogarty MD; Janss AJ; Liu X; Zhao H; Eggert A; Sutton LN; Rorke LB; Brodeur GM; Phillips PC
Clin Cancer Res; 2001 Aug; 7(8):2425-33. PubMed ID: 11489822
[TBL] [Abstract][Full Text] [Related]
36. Pigmented primitive neuroectodermal tumor with multipotential differentiation in cerebellum (pigmented medullomyoblastoma). A case with light- and electron-microscopic, and immunohistochemical analysis.
Kalimo H; Paljärvi L; Ekfors T; Pelliniemi LJ
Pediatr Neurosci; 1987; 13(4):188-95. PubMed ID: 3136447
[TBL] [Abstract][Full Text] [Related]
37. Differentiation in medulloblastomas and other primitive neuroectodermal tumours.
Sime PJ; Gordon A; Hooper ML; Bell JE
Br J Neurosurg; 1989; 3(1):89-100. PubMed ID: 2789717
[TBL] [Abstract][Full Text] [Related]
38. Prognostic importance of cellular differentiation in medulloblastoma of childhood.
Packer RJ; Sutton LN; Rorke LB; Littman PA; Sposto R; Rosenstock JG; Bruce DA; Schut L
J Neurosurg; 1984 Aug; 61(2):296-301. PubMed ID: 6737054
[TBL] [Abstract][Full Text] [Related]
39. Contributions of immunohistochemistry to the problem of differentiation in medulloblastoma.
Giordana MT; Mauro A; Migheli A; Schiffer D
Ital J Neurol Sci; 1983 Dec; 4(4):411-5. PubMed ID: 6674239
[TBL] [Abstract][Full Text] [Related]
40. Glial fibrillary acidic protein in medulloblastomas and other embryonic CNS tumours of children.
Schindler E; Gullotta F
Virchows Arch A Pathol Anat Histopathol; 1983; 398(3):263-75. PubMed ID: 6298997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
